07/18/2025
4:00 PM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2025
3:15 PM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2025
7:00 AM | Fisher Alan (Reporting)
Neuphoria Therapeutics Inc. (Issuer)
Neuphoria Therapeutics Inc. (Issuer)
Neuphoria Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2025
7:01 AM | Neuphoria Therapeutics Inc. (Issuer)
Neuphoria Therapeutics Inc. (Issuer)
Neuphoria Therapeutics (Issuer)
Wilson David Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2025
7:02 AM | Neuphoria Therapeutics Inc. (Issuer)
Neuphoria Therapeutics Inc. (Issuer)
Neuphoria Therapeutics (Issuer)
Ryan Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2025
7:03 AM | Davies Peter Miles Winston (Reporting)
Neuphoria Therapeutics Inc. (Issuer)
Neuphoria Therapeutics Inc. (Issuer)
Neuphoria Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2025
7:04 AM | Neuphoria Therapeutics Inc. (Issuer)
Neuphoria Therapeutics Inc. (Issuer)
Neuphoria Therapeutics (Issuer)
Papapetropoulos Spyros (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:06 PM | ARMISTICE CAPITAL, LLC (Filed by)
Neuphoria Therapeutics Inc. (Subject)
Neuphoria Therapeutics Inc. (Subject)
Neuphoria Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
7:58 AM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/12/2025
5:45 AM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form 424B5 | |
02/04/2025
5:15 AM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for NEUP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Neuphoria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/29/2025
11:15 PM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form EFFECT | |
01/28/2025
11:16 AM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/27/2025
8:23 AM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/14/2025
4:28 PM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2025
11:15 PM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form EFFECT | |
01/07/2025
5:18 AM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form S-3/A | |
12/29/2024
11:15 PM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form EFFECT | |
12/29/2024
11:15 PM | Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics Inc. (Filer)
Neuphoria Therapeutics (Filer)
| Form EFFECT | |
12/23/2024
4:14 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
3:56 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form 15-12G | |
12/23/2024
4:02 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form POS AM | |
12/23/2024
4:03 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form POS AM | |
12/16/2024
3:46 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
4:02 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
3:01 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
3:41 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2024
2:25 PM | ARMISTICE CAPITAL, LLC (Filed by)
BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
8:03 AM | BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
11/13/2024
3:55 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form DEFA14A | |
10/10/2024
4:00 PM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
7:47 AM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form PRE 14A | |
10/07/2024
5:10 PM | Apeiron Investment Group Ltd. (Filed by)
BIONOMICS LIMITED/FI (Subject)
BIONOMICS LIMITED/FI (Subject)
Neuphoria Therapeutics (Subject)
| Form SC 13D/A | |
09/30/2024
5:38 AM | BIONOMICS LIMITED/FI (Filer)
BIONOMICS LIMITED/FI (Filer)
Neuphoria Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
